JBT Corp. (JBT) Misses Q2 EPS by 17c ; Offers Guidance

JBT Corp. (NYSE: JBT) reported Q2 EPS of $1.05, $0.17 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $402 million versus the consensus estimate of $434.32 million.

GUIDANCE:

JBT Corp. sees FY2024 EPS of $5.05-$5.35, versus the consensus of $5.16. JBT Corp. sees FY2024 revenue of $1.71-1.75 billion, versus the consensus of $1.74 billion.

For earnings history and earnings-related data on JBT Corp. (JBT) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Macquarie favors BSL, RWC, REH in Australian earnings season
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c